The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business, and policy have helped advance the frontiers of the field. PRESENTER | Brian Munroe, Founder, Board Member, Personalized Medicine Coalition AWARDEE | Emily Kramer-Golinkoff, Co-Founder, Emily’s Entourage
Personalized medicine depends on a strong diagnostics industry, which faces an uncertain future. This panel examines the perspectives of investors and senior executives on the financial future of the industry. MODERATOR | Michael D. Goldberg, Executive Chairman, DNAnexus, Chairman, CareDx Brian Caveney, M.D., Chief Medical & Scientific Officer, Labcorp Michael Pellini, M.D., General Partner, S32 […]
Illumina, a $23 billion genomic sequencing technology company, has broad-based ambitions for personalized medicine to transform health care across multiple fronts. CEO Jacob Thaysen reveals his vision for the future. MODERATOR | Clifton Leaf, former Editor-in-Chief, Fortune magazine KEYNOTE SPEAKER | Jacob Thaysen, Ph.D., CEO, Illumina
For nearly two decades, Amgen, a global leader in the pharmaceutical industry, has leaned into the development of innovative personalized medicines that promise big benefits for relatively small patient populations. Executive Vice President David Reese discusses the future of the company and the field. MODERATOR | Clifton Leaf, former Editor-in-Chief, Fortune magazine KEYNOTE SPEAKER | David […]
SPEAKER | Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
